Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Pfizer Vaccine Supply Chain Problems

By London Capital GroupMarket OverviewDec 04, 2020 08:13
uk.investing.com/analysis/pfizer-vaccine-supply-chain-problems-200450683
Pfizer Vaccine Supply Chain Problems
By London Capital Group   |  Dec 04, 2020 08:13
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

MARKETS

The S&P 500 fell slightly from record high. Major U.S stocks indices cut gains quickly in the final hour of trading after Dow Jones reported Pfizer (NYSE:PFE) now expects to ship half of the doses it had previously planned this year after finding raw materials in early production that didn’t meet its standard. European markets close mixed amid Brexit uncertainty. The Stoxx 600 closed marginally above the flatline, with the travel and leisure stocks surging 3.5%, while chemicals shares declined 1.1%. The dollar plunged while Bitcoin and Gold rose.

WRAP

News

• Asia-Pacific stocks trade mixed amid Covid vaccine concerns; SMIC shares in Hong Kong suspended as Pentagon blacklists the China chipmaker SMIC (as well as oil producer CNOOC);
• U.S. reportedly in talks with Huawei CFO on deal to send her back to China if she admits to wrongdoing;
• Credit Suisse (SIX:CSGN) says Asian stocks will kick off an ‘earnings super-cycle’ in 2021;
• JPMorgan (NYSE:JPM) says emerging markets are ‘under owned,’ stocks could rally as much as 20%;
• Completely driverless cars are being tested in China for the first time;
• Pfizer cuts Vaccine rollout target by half due to "Supply Chain Obstacles";
• Cruise stocks surged yesterday after Bank of America (NYSE:BAC) lifts price targets on vaccine hopes: Carnival (NYSE:CCL) and Norwegian Cruise Line Holdings soared as much as 11.1% and 9.9%, respectively. Royal Caribbean Cruises gained as much as 5.5%;
• Stock Valuations surpass 1929 levels: the CAPE ratio has now climbed to its highest ever level outside of the 2000 bubble period;
• U.S. jobless claims hit pandemic-era low as hiring continues even with rising coronavirus cases;
• U.S. reports record 2,800 Covid deaths in a single day, hospitals pushed to the limits;
• UK regulator defends rapid approval of vaccine after Fauci criticism;
• Mitch McConnell says US stimulus deal ‘within reach’;
• DOJ sues Facebook (NASDAQ:FB) for discriminating against US Workers, reserving Jobs for H1-B Workers;
• Luminar Rises in Market Debut, Making 25-Year-Old Founder a Billionaire. The company, which produces sensor technology for self-driving cars, was started by founder and CEO Austin Russell when he was 17;
• Chevron (NYSE:CVX) slashes spending plans as Coronavirus hammers oil demand;
• Cerberus pushed to install Colm Kelleher as Deutsche Bank (DE:DBKGn) chair. US buyout group tapped former Morgan Stanley (NYSE:MS) president in an effort to replace Paul Achleitner.

What Else?

• OPEC, Allies agree to increase Output by 500,000 Barrels a Day. The agreement ends a standoff over oil policy between the two sides, promising a modest boost to global supplies as oil markets tighten;
• Tough Macron stance leaves Brexit deal hanging in balance: French president’s intervention on fish and state aid alarms British prime minister Boris Johnson;
• 'Immunity Cards' to be issued to all Americans; enable CDC To Track COVID-19 Vaxx status in database;
• Stripe to offer Banking Services in deal with Goldman Sachs (NYSE:GS), Citigroup (NYSE:C);
• Boeing (NYSE:BA) clinches first firm order for 737 Max since aircraft’s grounding. Multibillion-dollar Ryanair deal marks start of efforts to rehabilitate jet after two fatal accidents;
• ECB warns banks are ‘all over the place’ on bad loan preparations;
• Vitol agrees to pay $160m in bribery and manipulation settlements;
• ‘Tiger cub’ hedge fund Coatue surges to 52% gain: stakes in Tesla and PayPal, and a bet against Wirecard, make 2020 a banner year.

Earnings update

• DocuSign shares gained 6.2% after-hours after Q3 beats on the top and bottom lines and billings. The company also provided upside revenue guidance for the quarter and year.

The Day Ahead

• Macro: IHS Markit Sector PMI for Asia, Europe, Global, Australia retail sales, India monetary policy decision, IHS Markit Construction PMI for Eurozone, Germany, France, Italy and UK, US nonfarm payrolls, jobless rate, earnings, US exports, imports, trade balance, factory orders.

Quote of the day

“The difference between stupidity and genius is that genius has its limits.” – Albert Einstein” .

Original Post

Pfizer Vaccine Supply Chain Problems
 

Related Articles

Pfizer Vaccine Supply Chain Problems

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Jean Nel
Jean Nel Dec 20, 2020 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
new it will happen cannot trust pfizer
Jean Nel
Jean Nel Dec 20, 2020 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I knew
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email